Literature DB >> 31727289

Identifying the Very-High-Risk Atherosclerotic Cardiovascular Disease Patient: Does It Really Matter?

Nathan D Wong1.   

Abstract

Entities:  

Keywords:  anticholesteremic agents; atherosclerosis; cardiovascular disease; guideline as topic; hypercholesterolemia; risk

Mesh：

Substances：

Year:  2019        PMID： 31727289     DOI： 10.1016/j.jacc.2019.09.023

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease.

Authors:  Aparna Sajja; Hsin-Fang Li; Kateri J Spinelli; Amir Ali; Salim S Virani; Seth S Martin; Ty J Gluckman
Journal:  Am J Prev Cardiol       Date:  2021-04-27

2.  Improvement of evaluation in Chinese patients with atherosclerotic cardiovascular disease using the very-high-risk refinement: a population-based study.

Authors:  Sha Li; Hui-Hui Liu; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Rui-Xia Xu; Qian Dong; Jian-Jun Li
Journal:  Lancet Reg Health West Pac       Date:  2021-10-21

3.  Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study.

Authors:  Litong Qi; Jiyan Chen; Xiaodong Li; Xiaoyong Qi; Chunhua Ding; Xiaoping Chen; Xiang Gu; Wenliang Xiao; Shuiping Zhao; Yugang Dong; Mingqi Zheng; Kai Huang; Liangqiu Tang; Xiaomei Guo; Fang Wang; Guosheng Fu; Junxia Li; Yong Huo
Journal:  Front Cardiovasc Med       Date:  2022-08-16

4.  Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.

Authors:  Nathan D Wong; Yanglu Zhao; Pin Xiang; Blai Coll; J Antonio G López
Journal:  Am J Cardiol       Date:  2020-09-28       Impact factor: 2.778
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.